- 全部删除
您的购物车当前为空
ST7612AA1 是一种新型有效且可口服的 HDAC 抑制剂,作为作为HIV-1潜伏期再激活剂。ST7612AA1 在体内外实验中低浓度显示出显著的抗肿瘤活性。ST7612AA1 具有潜在的抗癌活性,可用于研究疟疾。


为众多的药物研发团队赋能,
让新药发现更简单!
ST7612AA1 是一种新型有效且可口服的 HDAC 抑制剂,作为作为HIV-1潜伏期再激活剂。ST7612AA1 在体内外实验中低浓度显示出显著的抗肿瘤活性。ST7612AA1 具有潜在的抗癌活性,可用于研究疟疾。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,300 | In stock | |
| 5 mg | ¥ 3,250 | In stock | |
| 10 mg | ¥ 4,750 | In stock | |
| 25 mg | ¥ 7,480 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,600 | In stock | |
| 500 mg | ¥ 27,300 | In stock |
ST7612AA1 相关产品
| 产品描述 | ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo. ST7612AA1 has potential anticancer activity and can be used to study malaria. |
| 分子量 | 405.51 |
| 分子式 | C20H27N3O4S |
| CAS No. | 1428535-92-5 |
| Smiles | C(N[C@H](C(NC1=CC=CC=C1)=O)CCCCCSC(C)=O)(=O)[C@@H]2NC(=O)CC2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (135.63 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容